Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.23.2
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Common Shares Issuable
Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2021 $ 3 $ 101   $ 656,033 $ (547,463) $ 117,203 $ 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 101,435,505          
Balance at Mar. 31, 2022 $ 3 $ 106   660,973 (563,223) 95,719 193,578
Balance (in shares) at Mar. 31, 2022 3,427,138 106,321,875          
Balance at Dec. 31, 2021 $ 3 $ 101   656,033 (547,463) 117,203 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 101,435,505          
Stock-based compensation expense       10,644     10,644
Issuance of common stock related to equity plans   $ 3   (3)      
Issuance of common stock related to equity plans (in shares)   2,646,375          
Issuance of common stock under ESPP       99     99
Issuance of common stock under ESPP (in shares)   135,464          
Issuance of common stock for at-the-market offering, net   $ 4   5,523     5,527
Issuance of common stock for at-the-market offering, net (in shares)   3,500,303          
Preferred A dividends declared and paid       (4,016)     (4,016)
Partner company's at-the-market offering, net       14,476     14,476
Partner company's exercise of options for cash       111     111
Issuance of common stock under partner company's ESPP       116     116
Partner company's dividends declared and paid       (375)     (375)
Partner company's net settlement of shares withheld for taxes       (1,698)     (1,698)
Reversal of partner company's common shares for research and development expenses       (35)     (35)
Warrants in conjunction with Oaktree Note       384     384
Non-controlling interest in partner companies       (19,568)   19,568  
Net loss attributable to non-controlling interest           (66,292) (66,292)
Net loss attributable to common stockholders         (37,116)   (37,116)
Balance at Jun. 30, 2022 $ 3 $ 108   $ 661,691 (584,579) 70,479 147,702
Balance (in shares) at Jun. 30, 2022 3,427,138 107,717,647   661,691,000      
Balance at Mar. 31, 2022 $ 3 $ 106   $ 660,973 (563,223) 95,719 193,578
Balance (in shares) at Mar. 31, 2022 3,427,138 106,321,875          
Stock-based compensation expense       5,081     5,081
Issuance of common stock related to equity plans (in shares)   176,406          
Issuance of common stock under ESPP       $ 99     99
Issuance of common stock under ESPP (in shares)   135,464          
Issuance of common stock for at-the-market offering, net   $ 2         1,301
Issuance of common stock for at-the-market offering, net (in shares)   1,083,902   1,299,000      
Preferred A dividends declared and paid       $ (2,008)     (2,008)
Partner company's at-the-market offering, net       (3,693)     (3,693)
Partner company's exercise of options for cash       111     111
Partner company's dividends declared and paid       (188)     (188)
Reversal of partner company's common shares for research and development expenses       (35)     (35)
Non-controlling interest in partner companies       (7,334)   7,334  
Net loss attributable to non-controlling interest           (32,574) (32,574)
Net loss attributable to common stockholders         (21,356)   (21,356)
Balance at Jun. 30, 2022 $ 3 $ 108   $ 661,691 (584,579) 70,479 147,702
Balance (in shares) at Jun. 30, 2022 3,427,138 107,717,647   661,691,000      
Balance at Dec. 31, 2022 $ 3 $ 110   $ 675,841 (634,233) 8,304 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 110,494,245          
Balance at Mar. 31, 2023 $ 3 $ 130   693,433 (655,770) (17,990) 19,806
Balance (in shares) at Mar. 31, 2023 3,427,138 130,417,161          
Balance at Dec. 31, 2022 $ 3 $ 110   675,841 (634,233) 8,304 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 110,494,245          
Stock-based compensation expense       8,948     8,948
Issuance of common stock related to equity plans   $ 3   (3)      
Issuance of common stock related to equity plans (in shares)   2,757,850          
Issuance of common stock for public offering, net   $ 17   13,137     13,154
Issuance of common stock for public offering, net (in shares)   16,642,894          
Issuance of common stock for at-the-market offering, net   $ 2   1,166     1,168
Issuance of common stock for at-the-market offering, net (in shares)   1,596,381          
Common shares issued for dividend on partner company's convertible preferred shares     $ 23 108     131
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   165,999          
Preferred A dividends declared and paid       (4,016)     (4,016)
Partner company's offering, net       21,977     21,977
Partner company's exercise of options for cash       3     3
Issuance of common stock under partner company's ESPP       88     88
Partner company's dividends declared and paid       (371)     (371)
Reversal of partner company's common shares for research and development expenses       1,233     1,233
Warrants in conjunction with Oaktree Note       272     272
Deconsolidation of Aevitas noncontrolling interest           5,891 5,891
Non-controlling interest in partner companies       (19,486)   19,486  
Net loss attributable to non-controlling interest           (68,133) (68,133)
Net loss attributable to common stockholders         (46,313)   (46,313)
Balance at Jun. 30, 2023 $ 3 $ 132 23 698,897 (680,546) (34,452) (15,943)
Balance (in shares) at Jun. 30, 2023 3,427,138 131,657,369          
Balance at Mar. 31, 2023 $ 3 $ 130   693,433 (655,770) (17,990) 19,806
Balance (in shares) at Mar. 31, 2023 3,427,138 130,417,161          
Stock-based compensation expense       4,217     4,217
Issuance of common stock related to equity plans (in shares)   82,728          
Issuance of common stock for public offering, net       (41)     (41)
Issuance of common stock for at-the-market offering, net   $ 2   719     721
Issuance of common stock for at-the-market offering, net (in shares)   991,481          
Common shares issued for dividend on partner company's convertible preferred shares     23 108     131
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   165,999          
Preferred A dividends declared and paid       (2,008)     (2,008)
Partner company's offering, net       14,460     14,460
Partner company's exercise of options for cash       3     3
Issuance of common stock under partner company's ESPP       88     88
Partner company's dividends declared and paid       (185)     (185)
Reversal of partner company's common shares for research and development expenses       3     3
Warrants in conjunction with Oaktree Note       272     272
Deconsolidation of Aevitas noncontrolling interest           5,891 5,891
Non-controlling interest in partner companies       (12,172)   12,172  
Net loss attributable to non-controlling interest           (34,525) (34,525)
Net loss attributable to common stockholders         (24,776)   (24,776)
Balance at Jun. 30, 2023 $ 3 $ 132 $ 23 $ 698,897 $ (680,546) $ (34,452) $ (15,943)
Balance (in shares) at Jun. 30, 2023 3,427,138 131,657,369